According to MarketsandMarkets™, the global Immunohistochemistry (IHC) Market is projected to grow from USD 3.55 billion in 2025 to USD 5.14 billion by 2030, registering a CAGR of 7.6% during the forecast period. Market growth is driven by increasing demand for advanced diagnostic techniques, particularly in oncology, along with favorable reimbursement policies supporting wider adoption of IHC testing.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=121632939
Browse
- 794 Market Data Tables
- 65 Figures
- 563 Pages and in-depth TOC on “ Immunohistochemistry Market – Global Forecast to 2030”.
The comprehensive reimbursement coverage in developed regions is significantly reducing patient out-of-pocket expenses, thereby increasing test volumes and driving demand for IHC instruments and reagents. However, inconsistencies in reimbursement frameworks across regions continue to pose challenges, potentially impacting the adoption of advanced and high-cost diagnostic solutions.
Key Market Insights
By product & service, the kits segment is expected to register the highest growth during the forecast period. This growth is driven by a notable shift toward standardized, ready-to-use solutions among diagnostic laboratories, hospitals, and research institutions. Integrated kits with pre-validated components streamline workflows, reduce manual intervention, and enhance reproducibility and efficiency—critical factors for both clinical diagnostics and research applications.
End User Insights
By end user, hospitals & diagnostic laboratories accounted for the largest share of the immunohistochemistry market in 2024. This dominance is attributed to the essential role of IHC in diagnosing a wide range of diseases, particularly cancer, infectious diseases, and autoimmune disorders. IHC remains a gold standard for identifying protein biomarkers, enabling precise disease characterization and supporting targeted therapy decisions. The increasing global burden of cancer and the growing trend of hospitals establishing in-house diagnostic capabilities are further driving segment growth.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=121632939
Regional Outlook
The Asia Pacific region accounted for the largest share of the immunohistochemistry market in 2024. Growth in this region is driven by rising healthcare investments, expanding access to diagnostic services, and increasing incidence of chronic diseases such as cancer. Government initiatives to strengthen healthcare infrastructure, along with the rapid expansion of private diagnostic laboratories and contract research organizations, are further supporting market growth. Additionally, countries such as Singapore and Thailand are emerging as key hubs for medical tourism, boosting demand for advanced diagnostic technologies.
Competitive Landscape
The immunohistochemistry market is highly competitive, with leading players focusing on innovation, strategic collaborations, and expansion initiatives. Key companies operating in this market include F. Hoffmann-La Roche Ltd, Danaher Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Merck KGaA, Bio-Rad Laboratories, Inc., Bio-Techne, Becton, Dickinson and Company, Takara Bio Inc., PHC Holdings Corporation, Enzo Biochem Inc., Sino Biological, Inc., OriGene Technologies, Inc., Cell Signaling Technology, Inc., Bio SB, Miltenyi Biotec, Sakura Finetek, EagleBio, Biocare Medical LLC, Elabscience BioInnovation Inc., Bio-Genex, Diagnostic BioSystems Inc., Histo-Line Laboratories, Rockland Immunochemicals, Inc., and CANDOR Bioscience GmbH, among others.
As precision diagnostics and personalized medicine continue to advance, the immunohistochemistry market is poised for sustained growth, supported by technological innovation, increasing disease burden, and expanding global access to advanced diagnostic solutions.
Related Reports:
In Vitro Diagnostics Market – Global Forecast to 2030
Immunoassay Market – Global Forecast to 2030
Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/immunohistochemistry-market-121632939.html